These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2572126)

  • 21. Non-neuronal cells of rat hypothalamus in dissociated cell culture. Evidence that neurophysin modulates growth and DNA synthesis of non-neuronal cells.
    Worley RT; Pickering BT
    Cell Tissue Res; 1984; 237(1):161-8. PubMed ID: 6478478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of the rat prolactin releasing factor.
    Shin SH; Papas S; Obonsawin MC
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2036-43. PubMed ID: 3123042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions.
    Cheung CY; Neill AC; Weiner RI
    Neuroendocrinology; 1981 Jun; 32(6):370-4. PubMed ID: 6165920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The physiological release of specific individual neurophysins into the circulation of pigs.
    Dax EM; Cumming IA; Lawson RA; Johnston CI
    Endocrinology; 1977 Mar; 100(3):635-41. PubMed ID: 401018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Lactotroph Heterogeneity in Lactating Rats and in vitro Modification by 17Beta-Estradiol.
    Zhang J; Chen C; Kukstas LA; Vincent JD; Israel JM
    J Neuroendocrinol; 1990 Dec; 2(6):815-23. PubMed ID: 19215424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine creates a physical barrier to inhibit prolactin release in mammotrophs of estradiol-primed male rats.
    Reifel CW; Saunders SL; Shin SH
    Neuroendocrinology; 1983; 36(3):242-8. PubMed ID: 6835477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nonoxytocinergic prolactin releasing factor and a nondopaminergic prolactin inhibiting factor in bovine neurointermediate lobe extracts: in vitro and in vivo studies.
    Samson WK; Martin L; Mogg RJ; Fulton RJ
    Endocrinology; 1990 Mar; 126(3):1610-7. PubMed ID: 2106431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute stimulation of prolactin release by estradiol: mediation by the posterior pituitary.
    Murai I; Ben-Jonathan N
    Endocrinology; 1990 Jun; 126(6):3179-84. PubMed ID: 2351112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
    Domae M; Yamada K; Hanabusa Y; Matsumoto S; Furukawa T
    Eur J Pharmacol; 1990 Apr; 179(1-2):75-82. PubMed ID: 2142088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurophysin stimulates prolactin release in in vitro and in vivo systems.
    Shin SH; Harvey L; Heisler R; Obonsawin M
    Ann N Y Acad Sci; 1993 Jul; 689():667-9. PubMed ID: 8373073
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxytocin, vasopressin, and estrogen-stimulated neurophysin: daily patterns of concentration in cerebrospinal fluid.
    Perlow MJ; Reppert SM; Artman HA; Fisher DA; Self SM; Robinson AG
    Science; 1982 Jun; 216(4553):1416-8. PubMed ID: 7201163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular organization of neurophysins, oxytocin, (8-lysine)-vasopressin and adenosine triphosphatase in porcine posterior pituitary lobes.
    Pickup JC; Johnston CI; Nakamura S; Uttenthal LO; Hope DB
    Biochem J; 1973 Mar; 132(3):361-71. PubMed ID: 4269306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ; Samson WK
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
    Shull JD; Gorski J
    Mol Pharmacol; 1990 Feb; 37(2):215-21. PubMed ID: 1968222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypothalamic-neurohypophysial system of the rat: localization and quantitation of neurophysin by light microscopic immunocytochemistry in normal rats and in Brattleboro rats deficient in vasopressin and a neurophysin.
    Sokol HW; Zimmerman EA; Sawyer WH; Robinson AG
    Endocrinology; 1976 May; 98(5):1176-88. PubMed ID: 1261512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of a non-dopaminergic and non-GABAergic prolactin release-inhibiting factor (PIF) in sheep stalk-median eminence.
    Mizunuma H; Khorram O; McCann SM
    Proc Soc Exp Biol Med; 1985 Jan; 178(1):114-20. PubMed ID: 2857051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thioridazine stimulates prolactin secretion in man.
    Sachar EJ; Gruen PH; Karasu TB; Altman N; Frantz AG
    Arch Gen Psychiatry; 1975 Jul; 32(7):885-6. PubMed ID: 239662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies.
    Blask DE; Vaughan MK; Reiter RJ; Johnson LY; Vaughan GM
    Endocrinology; 1976 Jul; 99(1):152-62. PubMed ID: 7446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
    Soaje M; Valdez S; Bregonzio C; Penissi A; Deis RP
    Neuroendocrinology; 2006; 84(1):58-67. PubMed ID: 17090971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonadal steroids influence neurophysin II distribution in the forebrain of normal and mutant mice.
    Mayes CR; Watts AG; McQueen JK; Fink G; Charlton HM
    Neuroscience; 1988 Jun; 25(3):1013-22. PubMed ID: 3405422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.